U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3915139151An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid LevelsNot yet recruitingNo Results AvailableDyslipidemiaOther: VASCAZENhttps://ClinicalTrials.gov/show/NCT02052986
3915239152Efficacy of Propolis Varnish Against Oral BiofilmCompletedNo Results AvailableStreptococcal Infections|Saliva AlteredOther: Propolis varnishhttps://ClinicalTrials.gov/show/NCT02052973
3915339153CetuGEXâ„¢ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck CancerRecruitingNo Results AvailableCarcinoma, Squamous Cell of Head and NeckDrug: CetuGEXâ„¢|Drug: Cetuximab|Drug: Combination of Cisplatin and 5-Fluorouracilhttps://ClinicalTrials.gov/show/NCT02052960
3915439154Co-LEsions in Alzheimer Disease and Related DisordersNot yet recruitingNo Results AvailableAlzheimer's Disease|Cerebrovascular Disease|Lewy Body DiseaseRadiation: SPECT-DaTscanhttps://ClinicalTrials.gov/show/NCT02052947
3915539155Safety of Sublingual dmLT for ETECRecruitingNo Results AvailableGastroenteritis Escherichia ColiBiological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine|Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccinehttps://ClinicalTrials.gov/show/NCT02052934
3915639156Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant ChemoradiotherapyRecruitingNo Results AvailableRectal CancerProcedure: Rectal resection|Other: Observationhttps://ClinicalTrials.gov/show/NCT02052921
3915739157Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch SyndromeRecruitingNo Results AvailableLynch SyndromeOther: Laboratory Biomarker Analysis|Drug: Naproxen|Other: Placebohttps://ClinicalTrials.gov/show/NCT02052908
3915839158Utility of Presepsin in Distinguishing Between Sepsis and SIRSCompletedNo Results AvailableSIRS|Sepsishttps://ClinicalTrials.gov/show/NCT02052895
3915939159Study of Romiplostim Versus Observation for Chemotherapy Induced ThrombocytopeniaRecruitingNo Results AvailableIsolated Chemotherapy-induced ThrombocytopeniaBiological: romiplostim,|Other: Control cohorthttps://ClinicalTrials.gov/show/NCT02052882
3916039160Spirometric Detection of Esophageal IntubationNot yet recruitingNo Results AvailableHypoxia|HypoventilationProcedure: esophagus intubationhttps://ClinicalTrials.gov/show/NCT02052869
3916139161Anterior Cruciate Ligament (ACL) Tunnel Widening Comparing All-inside and Interference Screw Fixation TechniqueCompletedNo Results AvailableAnterior Cruciate Ligament Injury|Knee Injury|ACL Injuryhttps://ClinicalTrials.gov/show/NCT02052856
3916239162Impact Evaluation of the Steps to Success ProgramEnrolling by invitationNo Results AvailablePregnancyBehavioral: Steps to Success|Behavioral: Traditional Healthy Familieshttps://ClinicalTrials.gov/show/NCT02052843
3916339163Impact Evaluation of the Wise Guys ProgramEnrolling by invitationNo Results AvailableSexual Behavior|Sexually Transmitted InfectionsBehavioral: Wise Guyshttps://ClinicalTrials.gov/show/NCT02052830
3916439164Randomized, Prospective Evaluation of the Toad Brace in Plantar Ulcer Off-loading and HealingRecruitingNo Results AvailableDiabetic Foot|Pedal UlcersDevice: Optimal Medical Therapy Debridement + Toad Brace|Other: Optimal Medical Therapy - Debridementhttps://ClinicalTrials.gov/show/NCT02052817
3916539165Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential TherapeuticsRecruitingNo Results AvailableHeart Failurehttps://ClinicalTrials.gov/show/NCT02052804
3916639166An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS SMNRx-CS2 or ISIS SMNRx-CS10Active, not recruitingNo Results AvailableSpinal Muscular AtrophyDrug: ISIS-SMNRxhttps://ClinicalTrials.gov/show/NCT02052791
3916739167A Dose Finding Study Followed by a Safety and Efficacy Study in Patients With Advanced Solid Tumors or Multiple Myeloma With FGF/FGFR-Related AbnormalitiesRecruitingNo Results AvailableSolid Tumors|Multiple MyelomaDrug: TAS-120https://ClinicalTrials.gov/show/NCT02052778
3916839168AnalyST & Brugada Syndrome - Feasibility StudyCompletedNo Results AvailableBrugada SyndromeDevice: ECG continuous recording (Analyze ST)https://ClinicalTrials.gov/show/NCT02052765
3916939169A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne LesionsCompletedHas ResultsSkin DiseasesDrug: 3% Benzoyl Peroxide|Drug: 3% Benzoyl Peroxide Placebo|Drug: Neutrogena Rapid Clear®https://ClinicalTrials.gov/show/NCT02052752
3917039170Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status EpilepticusCompletedNo Results AvailableSuper-refractory Status EpilepticusDrug: SAGE-547https://ClinicalTrials.gov/show/NCT02052739
3917139171A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.CompletedNo Results AvailableClostridium DifficileBiological: C. difficile vaccine with adjuvant|Biological: Placebo|Biological: C. difficile vaccine with adjuvant|Biological: placebohttps://ClinicalTrials.gov/show/NCT02052726
3917239172Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted StateCompletedNo Results AvailableUrologic DiseasesDrug: Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|Drug: Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsulehttps://ClinicalTrials.gov/show/NCT02052713
3917339173A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453CompletedNo Results AvailableHealthyDrug: LFX453 H1|Drug: LFX453 L1|Drug: LFX453 H2|Drug: LFX453 L2|Drug: Imiquimod|Drug: Placebo 1|Drug: Placebo 2https://ClinicalTrials.gov/show/NCT02052687
3917439174Retained Urine Volume and Bacteriuria in Traditional Versus Vented Urine Drainage SystemsWithdrawnNo Results AvailableBacteriuriaDevice: Vented urinary drainage system|Device: Non-vented urinary drainage systemhttps://ClinicalTrials.gov/show/NCT02052674
3917539175This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrixâ„¢ HexaCompletedHas ResultsHepatitis BBiological: Engerixâ„¢-B Kinderhttps://ClinicalTrials.gov/show/NCT02052661
3917639176Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain TumorsRecruitingNo Results AvailableGlioblastoma Multiforme|Glioma|Gliosarcoma|Malignant Brain TumorDrug: Indoximod|Drug: Temozolomidehttps://ClinicalTrials.gov/show/NCT02052648
3917739177Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.TerminatedNo Results AvailableNon-ST Elevation Acute Coronary SyndromeDrug: ticagrelor|Drug: clopidogrelhttps://ClinicalTrials.gov/show/NCT02052635
3917839178Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101CompletedNo Results AvailableSubcutaneous FatProcedure: Examinations and surveyshttps://ClinicalTrials.gov/show/NCT02052622
3917939179A Phase 3 Clinical Study of KHK 4827Active, not recruitingNo Results AvailablePsoriasis Vulgaris,|Psoriatic Arthritis,|Pustular Psoriasis,|Psoriatic ErythrodermaDrug: KHK4827 140mg SC|Drug: KHK4827 210mg SChttps://ClinicalTrials.gov/show/NCT02052609
3918039180Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 YeaActive, not recruitingNo Results AvailableHerpes ZosterBiological: Herpes Zoster vaccine GSK 1437173A|Biological: Boostrixhttps://ClinicalTrials.gov/show/NCT02052596

* Görseller ve İçerik tekif hakkına sahip olabilir